Emergent Resistance to Dolutegravir Among INSTI-Naïve Patients on First-line or Second-line Antiretroviral Therapy: A Review of Published Cases

None of the licensing studies of dolutegravir (DTG) reported any treatment-emergent resistance among DTG-treated individuals, though virological failure in treatment-naïve and treatment-experienced, integrase strand transfer inhibitor (INSTI)–naïve individuals has been reported in clinical practice....

Descripción completa

Detalles Bibliográficos
Autores principales: Cevik, Muge, Orkin, Chloe, Sax, Paul E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Perspectives
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7304932/
https://www.ncbi.nlm.nih.gov/pubmed/32587877
http://dx.doi.org/10.1093/ofid/ofaa202

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7304932/
https://www.ncbi.nlm.nih.gov/pubmed/32587877
http://dx.doi.org/10.1093/ofid/ofaa202

Ejemplares similares